Tranway21 Tech. (542923)
Asset PlayScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹7.1 |
| Market Cap | ₹8.23 Cr |
| P/E Ratio | 0 |
| ROCE | 0.92% |
| ROE | 0.61% |
| Dividend Yield | 0% |
| Profit Growth | -214.29% |
| Debt/Equity | — |
| Sales Growth | -16.99% |
| 52-Week Range | ₹3.55 — ₹7.1 |
| Sector | IT - Software |
| Book Value | ₹11.27 |
Strengths
- Trades at ₹7.10 versus book value ₹11.27, giving a P/B of 0.63 and apparent asset cushion
- Latest quarter still generated sales of ₹2 crore, so the business is operational
- No debt data indicates leverage risk is not the primary immediate concern, though disclosure is lacking
- Small market cap of ₹8 crore leaves room for a rare asset-backed special situation if losses reverse
Concerns
- Latest quarter net loss of ₹1 crore on ₹2 crore sales shows severe margin stress
- Sales declined 16.99% and profit growth fell 214%, pointing to a shrinking business
- ROE of 0.61% and ROCE of 0.92% are far below acceptable returns on capital
- Piotroski F-Score of 3/9 signals weak financial health and possible book value erosion
AI Analysis
This is not the kind of business I want to own. Tranway21 Tech has a market cap of only ₹8 crore, yet the latest quarter shows sales of just ₹2 crore and a net loss of ₹1 crore. Sales fell nearly 17% and profit growth collapsed by 214%. With a Piotroski F-Score of 3/9, the financial engine is struggling. The 0.61% ROE and 0.92% ROCE tell me that every rupee of book value earns almost nothing, far below what a passive owner should demand. At ₹7.10, the stock trades at 0.63 times book value of ₹11.27, so on paper it looks cheap. But Graham warned: a discount to book is only a margin of safety if the assets truly earn a return and management allocates capital honestly. Here, the latest loss is burning away that book value. The P/E is meaningless because earnings are negative. Being at the top of its 52-week range after such deterioration is not encouraging; the market is not offering a distressed bargain, it is simply offering hope. There is no dividend to compensate while I wait. A wonderful business at a fair price beats a poor business at a cheap price. This appears to be a microcap asset play at best, with falling revenue, negligible returns, and weak financial health. I would rather pass and wait for a company with a clear moat, or demand a far lower price with evidence that the balance sheet is not deteriorating. Numbers alone do not make a bargain.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer